EXC 001-203: A Phase 2, Randomized, Double-Blind, Within-Subject Controlled Study to Evaluate Efficacy and Safety of EXC 001 for the Amelioration of Scarring Following Revision of Medial Scars Resulting from Prior Breast Reduction or Mastopexy Surgery in

Project: Research project

Project Details

Effective start/end date12/16/0912/15/12


  • Excaliard Pharmaceuticals, Inc. (EXC 001-203)